The business of DNA nanotechnology: Commercialization of origami and other technologies

16Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

It is often argued that DNA nanotechnology has a multitude of possible applications. However, despite great advances in the understanding of the fundamental principles of the field, to date, there has been comparatively little commercial activity. Analysis of patent applications and company case studies suggests that this is now starting to change. The number of patent application filings is increasing, and new companies are being formed to exploit technologies based on nanoscale structures and devices made from DNA. There are parallels between the commercial developments in this field and those observed in other areas of innovation. Further commercialization is expected and new players will emerge.

Cite

CITATION STYLE

APA

Dunn, K. E. (2020, January 16). The business of DNA nanotechnology: Commercialization of origami and other technologies. Molecules. MDPI AG. https://doi.org/10.3390/molecules25020377

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free